These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21710813)

  • 1. Higher prevalence of cytomegalovirus pp65 antigenemia associated with lower CD4+ T lymphocyte count.
    Jahan M; Islam AK; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2011 Apr; 37(1):28-33. PubMed ID: 21710813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
    Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
    Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
    Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
    Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CMV pp65 antigen and IgM antibody detection for early recognition of CMV primary infection and reactivation.
    Jahan M; Tabassum S; Islam M
    Mymensingh Med J; 2008 Jan; 17(1):28-31. PubMed ID: 18285727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 50 cases of cytomegalovirus disease].
    Wang HL; Qiu ZF; Sheng RY; Zhao Y; Zhu XC; Hao YY; Fan HW; Lu W; Ma XJ; Liu ZY; Li TS
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):600-3. PubMed ID: 15355666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of flow cytometry in detecting CMV-PP65 antigenemia for the diagnosis of CMV hepatitis].
    Zhao HC; Xiang GQ; Shen HQ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):310-1. PubMed ID: 16635312
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
    Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
    J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients.
    Podzamczer D; Ferrer E; García A; Ramón JM; Niubó J; Santín M; Rufí G; Pérez JL; Martín R; Gudiol F
    Scand J Infect Dis; 1997; 29(3):223-7. PubMed ID: 9255879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
    Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
    Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.
    Capria S; Gentile G; Capobianchi A; Cardarelli L; Gianfelici V; Trisolini SM; Foà R; Martino P; Meloni G
    J Med Virol; 2010 Jul; 82(7):1201-7. PubMed ID: 20513085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of the extraction method with saline dextran in the pp65 antigenemia assay against human cytomegalovirus].
    Reina J; Ballesteros F; Galmes M; Mari M; Munar M
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):389-91. PubMed ID: 11153202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cytomegalovirus-matrix protein (pp65) in leukocytes of HIV-infected patients with painful peripheral neuropathy.
    Mastroianni CM; Sebastiani G; Folgori F; Ajassa C; Vullo V; Volpi A
    J Med Virol; 1994 Oct; 44(2):172-5. PubMed ID: 7852958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.